Stock RANI RANI THERAPEUTICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Rani Therapeutics Holdings, Inc.

Equities

RANI

US7530181004

Delayed Nasdaq
Other stock markets
 14:03:01 2024-04-29 EDT 		5-day change 1st Jan Change
6.66 USD -0.30% Intraday chart for Rani Therapeutics Holdings, Inc. -0.30% +100.30%
03-27 Canaccord Genuity Adjusts Rani Therapeutics Price Target to $9 From $21, Maintains Buy Rating MT
03-25 HC Wainwright Adjusts Price Target on Rani Therapeutics to $12 From $16, Keeps Buy Rating MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Canaccord Genuity Adjusts Rani Therapeutics Price Target to $9 From $21, Maintains Buy Rating
MT
HC Wainwright Adjusts Price Target on Rani Therapeutics to $12 From $16, Keeps Buy Rating
MT
Wedbush Cuts Rani Therapeutics Holdings' PT to $8 From $20, Keeps Outperform Rating
MT
HC Wainwright Adjusts Price Target on Rani Therapeutics to $16 From $20, Maintains Buy Rating
MT
HC Wainwright Adjusts Price Target on Rani Therapeutics to $20 From $22, Keeps Buy Rating
MT
Wedbush Lifts Rani Therapeutics Holdings' Price Target to $20 From $19, Keeps Outperform Rating
MT
UBS Initiates Coverage on Rani Therapeutics With Buy Rating, $15 Price Target
MT
Wedbush Adjusts Rani Therapeutics Holdings Price Target to $19 From $17, Maintains Outperform Rating
MT
Wedbush Adjusts Price Target on Rani Therapeutics Holdings to $17 From $28, Keeps Outperform Rating
MT
HC Wainwright Initiates Rani Therapeutics Holdings at Buy With $22 Price Target
MT
Wedbush Starts Rani Therapeutics Holdings at Outperform With $28 Price Target
MT
RANI THERAPEUTICS : Canaccord Genuity Starts Rani Therapeutics Holdings at Buy With $29 Price Target
MT
RANI THERAPEUTICS : BTIG Starts Rani Therapeutics Holdings at Buy With $24 Price Target
MT
RANI THERAPEUTICS : Cantor Fitzgerald Starts Rani Therapeutics Holdings at Overweight with $23 Price Target
MT
RANI THERAPEUTICS : Stifel Starts Rani Therapeutics Holdings at Buy with $24 Price Target
MT
RANI THERAPEUTICS : BofA Securities Starts Rani Therapeutics Holdings at Buy with $23 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RANI Stock
  4. News Rani Therapeutics Holdings, Inc.
  5. Analyst Reco.